drugset
drugset / Trial / NCT00685906

AZD6140 Oral Contraceptive Interaction Study

NCT00685906 ↗

Phase 1 Completed 24 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to examine the effect of co-administration of AZD6140 and Nordette® on the blood levels of certain female hormones.

Timeline

Start
2008-04
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levonorgestrel and Ethinyl Estradiol Unknown — Oral
Subject Ticagrelor Small molecule 90 mg Oral

Indications

No indication recorded.